Philip Morris
FDA Sets Labeling Rules for Dietary Supplements Nutritional Data, Support for Health Claims Required
Fields
- Author
- Schwartz, J.
- Area
- NICOLI,DAVID/OFFICE
- Type
- NEWS, NEWS ARTICLE
- Site
- W6
- Named Person
- Cordaro, J.B.
- Hatch, O.G.
- Kessler, D.A.
- Kessler, G.
- Silverglade, B.
- Taylor, M.
- Hatch, O.G.
- Request
- Stmn/R1-072
- Stmn/R1-079
- Document File
- 2046936725/2046937271/Missing
- Named Organization
- Center for Science in the Public Interes
- Congress
- Council for Responsible Nutrition
- FDA, Food and Drug Administration
- Nutritional Health Alliance
- Congress
- Author (Organization)
- Wa Post
- Litigation
- Stmn/Produced
- Master ID
- 2046936726/6992
Related Documents:- 2046936726 Table of Contents
- 2046936727 A
- 2046936728-6731 FDA's Legally Suspect Actions Invite Challenge
- 2046936732-6735 FDA Paralysis Raises Health Care Costs
- 2046936736-6739 the Real Problem with Health Care in America: While Dr. David Kessler's FDA Fiddles, Medical Approvals Lag and Americans Die
- 2046936740-6743 What the FDA Doesn't Want You to Know Could Kill You
- 2046936744-6751
- 2046936752-6759
- 2046936760-6762 Guide to Medical Device Regulation FDA Issues First Warning Letter Citing Gmp Problems Under New Cpg
- 2046936763-6766 the Vitamin Uprising
- 2046936767-6780 Losing the Edge Overseas Patients Reap the Benefits of U.S.Research While Those Here Wait
- 2046936781-6783 Losing the Edge
- 2046936784 Feds: Toughen Regulation, Promote Research Improvements Needed, and They Are on the Way
- 2046936785-6786
- 2046936787-6789 Challenging FDA Authority
- 2046936790-6793 Speakeasies in A New Age of Prohibition
- 2046936794-6798 Who Is Happiest Politician in Washington Over Whitewater? Alfonse D'amato - Newt Gingrich - David Kessler?
- 2046936799-6800 Pro-Free Enterprise Group Challenges FDA's Authority to Regulate Drug Companies' Speech
- 2046936801-6802 Wlf Off-Label Use Suit Heats Up
- 2046936803-6805 Just Call Me 'doc'
- 2046936806-6810 Food and Drugs and Politics
- 2046936811-6813 Science and Technology Getting the Lead Out
- 2046936814 Forbes Fear of Falling 5 Ways to Protect Yourself in Scary Times
- 2046936815-6816 Book Burning
- 2046936817 If A Murderer Kills You, It's Homicide If A Drunk Driver Kills You, It's Manslaughter If the FDA Kills You, It's Just Being Cautious
- 2046936818-6820 Frustration for Medical Innovators
- 2046936821 Block That Innovation
- 2046936822-6823 Getting Even
- 2046936824-6826 Biotech Pipeline: Bottleneck Ahead
- 2046936827-6829 Consuming Interest Are We Safe From the FDA?
- 2046936830-6839 Saying Yes to Drugs Policy Analysis
- 2046936840-6858 Deadly Overcaution: FDA's Drug Approval Process
- 2046936859 B
- 2046936860-6861 Litigation Update Wlf Wins Suit Against FDA to Stop Overregulation of Heart Valves (Washington Legal Foundation V. Shalala)
- 2046936862-6863 Litigation Update Wlf Opposes FDA Efforts to Dismiss First Amendment Lawsuit (Washington Legal Foundation V. Kessler)
- 2046936864-6867 Dickinson's FDA Review
- 2046936868-6869 Wlf Urges Appeals Court to Enjoin Federal Policy Restricting Human Heart Valve Transplant (Washington Legal Foundation V. Shalala)
- 2046936870-6871 FDA Problems Slow US Andas
- 2046936872-6873 Taking the Heat An Aids Patient Champions A Risky Blood Treatment Banned in the U.S.
- 2046936874-6876 New Study Says Breast Implants Are Not A Health Risk
- 2046936877-6878 Wlf Sues FDA to Overturn Policy Restricting Information on Off-Labels Uses of Approved Drugs and Devices (Washington Legal Foundation V. Shalala)
- 2046936879 Ex-Inspector of F.D.A. Is Convicted of Bribery
- 2046936879A FDA Has No Position Yet
- 2046936880-6881 M-D-D-I Reports - 'the Gray Sheet'
- 2046936882 FDA Halts Test on Device That Shows Promise for the Victims of Cardiac Arrest
- 2046936883 Law Concerning Medical Devices Is Often Ignored
- 2046936884 Dairies, Drugs and Accusations
- 2046936884A FDA to Launch Campaign on New Labels for Food
- 2046936885 Probe of Three FDA Officials Sought Industry Ties Before Approval of Bovine Growth Hormone Are at Issue
- 2046936886-6889 Safety First How A Device to Aid in Breast Self-Exams If Kept Off the Market Other Nations Approved It But U.S. Demands Proof Simple Pad Isn't Risky Nine Year Battle with the FDA
- 2046936890-6892 Who Will Regulate the Regulators? If You Make A Mistake, Shouldn't You Own Up? Not If You're the FDA, Epa, or Ftc
- 2046936893-6894 None - A - Day Is the FDA Out to Take Your Vitamin?
- 2046936895 Will A New Government Program Net the Bad Fish?
- 2046936896-6897 FDA Responds to Wlf Petition Regarding Off-Label Drug Use by Indefinitely Postponing Issuance of Regulatory Guidelines
- 2046936898-6905 FDA Research: Overview
- 2046936906-6910 Government Report Finds Levels Safe Pesticide Residues in Your Children's Food
- 2046936911-6912 Wlf Urges FDA to Rescind Policy Restricting Information Flow on Off-Label Uses of Approved Drugs and Devices
- 2046936913 Regulatory Chokehold FDA Red Tape Dooms Transplant Drug
- 2046936914 FDA Called Lax in Overseeing Medical Sterilizers, Disinfectants
- 2046936916 Chemicals That Taint Seafood Concerns Continue Over Safety of Methylmercury Inspection Processes
- 2046936917 Lifesaving Devices Languish at the FDA
- 2046936918-6919 Wlf Sues FDA to Enjoin Federal Policy Restricting Human Heart Valve Transplants (Washington Legal Foundation V. Shalala)
- 2046936920 What's in Food? Answers Differ at 2 Agencies Manufacturers Fight to Keep FDA Label Rules From Encroaching on Ftc Ad Rules
- 2046936921 Reform the FDA
- 2046936922 Legal Beat FDA Approval Shield Firms in Injury Suits
- 2046936923 Water From A Bottle
- 2046936924 Commentary FDA and Our Split Medical Persona
- 2046936925-6926 FDA Assailed for Slow Testing of New Drugs
- 2046936927 Andrews Office Products Capitol Heights, Md (K)
- 2046936928-6947 Statement by David A. Kessler, M.D. Commissioner of Food and Drugs Before the Committee on Energy and Commerce Subcommittee on Health and the Environment U.S. House of Representatives
- 2046936948-6961 Filthy Food,Dubious Drugs, and Defective Devices: the Legacy of FDA's Antiquated Statute A Staff Report
- 2046936962-6968 Gao Reports on FDA-Related Topics 860000 to Present
- 2046936969 D
- 2046936970-6985 Statement by Louis W. Sullivan, M.D. Secretary of Health and Human Services Before the Committee on Labor and Human Resources U.S. Senate on the Final Report of the Advisory Committee on the FDA
- 2046936986-6992 Proposed Remarks of Dr. Charles Edwards Before the Senate Committee on Labor and Human Resources
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- dnn65e00
Document Images
Post
Washington, DC
FDASets Labeling Rules
For Dietary Supplements
Nutritional Data, Support for Health G7aims Required
-By-3ohn Schwartz
er,Lkm"eou sne et.
The Food and Drug Administration yes-
terday announced new rules governing la-
beling and health claims for vitamins, min-
erals, herbs and other dietary supplements.
The rules would prohibit supplement la-
bels from making anyhe3lth claims not sup-
ported by "significant agreement" within
the scientific community. They also would
require manufacturers of dietary supple-
ments to rewrite their labels to include de-
tailed nutritional information, including the
FDA-recommended daily intake of the sub-
stance.
The FDA will accept public comment on
the rules for 60 days; barring changes by
the agency, the regulations will become law
on Dec. 15.
The regulations have been harshly crit-
icized by supplement manufacturers, who
contend that the rules will unduly restrict
information available to consumers.
"FDA's goal is simple," FDA Commis-
sioner David A. Kessler said in a statement.
"We want people to have access to products
that are safe, and claims made about the
health and nutritional benefits should be
useful."
In an interview, Kessler said he consid-
ered the new regulations part of the agen-
cy's central mission. "Fifty years ago our
food and drug laws were designed to sep-
arate products made by snake oil salesmen
from drugs that really worked," he said.
"For every product and diet supplement
today that may be helpful to reduce disease,
there are hundreds of products marketed to
cure diseases like AIDS and cancer that are
unsubstantiated "
The FDA statement said that at least one
supplement claim already had been proven
sufficiently-manufacturers will be allowed
to print claims that folic acid might prevent
neural tube birth defects, as when babies
are bom with open spinal columns. The
agency said it also is looking at evidence
that antioxidants such as vitamin E might
have a role in preventing cancer and other
diseases.
At the same time, the agency pointed to
risks in supplements that still merit further
study, especially the popular use of amino
acids. A bad batch of the amino acid L-tryp-
tophan was linked to 1,500 illnesses and 38
deaths last year. The agency asked manu-
facturers of amino acids to submit infomia-
tion substantiating the safety of their prod-
ucts.
Manufacturers claim that FDA attempts
to regulate the supplements industry are in
fact an attempt to ban-and, by extension,
to restrict the consumers' right to buy-vi-
tamins and supplements. Gerald Kessler,
president of the industry group Nutritional
Health Alliance, linked vitamin-taking to
"our spiritual heritage," because medicinal
herbs are mentioned in the Bible, and to the
right to make informed choices. "You're
treading on the essence of democracy and
the essence of a spiritual legacy," he said.
J.B. Cordaro, president of the Council for
Responsible Nutrition, a manufacturers
trade association, said his group supports
federal regulation concerning quality stan-
dards and truthful labeling, but he added
that the FDA is too restrictive about the
health claims it allows manufacturers to
make.
The new requirements are designed to ,
bring supplements under the 1990 Nutn-
tional Labeling and Education Act, which
sets standards for labels on virtually all
processed foods. Congress temporarily ex-
cluded dietary supplements from the law
last year.
But manufacturers say the FDA is treat-
ing their products more like drugs, which
must go through rigorous and costly ap-
proval processes, than like food.
An industry-favored bill, proposed in
March by Sen. Orrin G. Hatch (R-Utah),
would allow broader product claims. Utah is
home to a $700 million supplements indus-
try.
Kessler said the agency is not out to ban
vitamins. "There is a lot of misinformation
out there," he said. "For the vast majority of
vitamins and minerals we have no problem."
But many supplements that are derived
from foods still might hurt consumers if
ingested in high concentrations, said Mike
Taylor, FDA deputy commissioner for pol-
icy. "Just because a substance exists in na-
ture does not make it safe."
Some consumer advocates applauded the
FDA's move. Bruce Silverglade, director of
legal affairs for the nonprofit Center for
Science in the Public Interest, said, "As con-
sumers increasingly turn toward supple-
ments to protect their health, it's all the
more important that the FDA rid the
shelves of health food stores.of products
that make shaky and downright dishonest
health claims."
0
